6505--Biologics by McKesson Specialty Pharmacy (Lenalidomide) (VA-26-00016920)

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

252-NETWORK CONTRACT OFFICE 12 (36C252)

Contract Value

Not provided

Codes & Classification
Solicitation Number

36C25226Q0072

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Classification Code

6505

Additional Details
Set Aside

None

Place of Performance

-

SourceSAM
Documents1
This procurement notice, titled "6505--Biologics by McKesson Specialty Pharmacy (Lenalidomide) (VA-26-00016920)," announces an award for the supply of Lenalidomide (commercially known as Revlimid) doses. The contract is managed by the 252-Network Contract Office 12, a federal office operating under the Department of Veterans Affairs, as indicated by the procurement identifier 36C25226Q0072. The primary objective of this procurement is to ensure the reliable provision of Lenalidomide, a critical biologic pharmaceutical used in the treatment of specific cancers and hematological disorders. The scope of the contract encompasses the manufacturing and delivery of this medication, aligning with NAICS Code 325412 (Pharmaceutical Preparation Manufacturing), which covers the production of pharmaceutical preparations intended for therapeutic use. The associated Product Service Code is 6505, further specifying the requirement for drugs and biologicals. The intended outcome of this procurement is to maintain an uninterrupted supply of Lenalidomide for eligible patients, supporting the Department of Veterans Affairs' mission to provide high-quality healthcare to veterans. The contract is awarded to McKesson Specialty Pharmacy, a recognized distributor with the capability to meet the stringent requirements for handling and delivering specialty biologic medications. Key requirements for this contract include adherence to all applicable federal regulations governing pharmaceutical manufacturing, storage, and distribution. The contractor is expected to ensure product integrity, timely delivery, and compliance with all safety and quality standards. The deliverables consist of specified doses of Lenalidomide, with the expectation that the supplier will maintain consistent availability throughout the contract period. The contracting activity is based in the jurisdiction of Network Contract Office 12, and all inquiries regarding this procurement should be directed to the primary contact, Arneil C Genus, who can be reached via email at [email protected] or by phone at 414-844-4800. This award notice is currently active and was posted on October 12, 2025. Contractors interested in similar future opportunities should note that this procurement falls under the pharmaceutical manufacturing classification and involves the supply of specialized biologic drugs. No set-aside requirements or special considerations are specified in the available information. Additional details and the official notice can be accessed through the SAM.gov opportunity ID 30d3197b91a54b3a86af9897008a3944. Overall, this procurement represents a critical supply chain activity supporting the Department of Veterans Affairs' healthcare delivery, with a focus on ensuring access to essential biologic therapies for the veteran population.